Correlation Between Kinnate Biopharma and Apellis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Kinnate Biopharma and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kinnate Biopharma and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kinnate Biopharma and Apellis Pharmaceuticals, you can compare the effects of market volatilities on Kinnate Biopharma and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kinnate Biopharma with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kinnate Biopharma and Apellis Pharmaceuticals.
Diversification Opportunities for Kinnate Biopharma and Apellis Pharmaceuticals
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Kinnate and Apellis is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Kinnate Biopharma and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and Kinnate Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kinnate Biopharma are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of Kinnate Biopharma i.e., Kinnate Biopharma and Apellis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Kinnate Biopharma and Apellis Pharmaceuticals
Given the investment horizon of 90 days Kinnate Biopharma is expected to under-perform the Apellis Pharmaceuticals. In addition to that, Kinnate Biopharma is 1.5 times more volatile than Apellis Pharmaceuticals. It trades about -0.08 of its total potential returns per unit of risk. Apellis Pharmaceuticals is currently generating about 0.0 per unit of volatility. If you would invest 5,521 in Apellis Pharmaceuticals on August 27, 2024 and sell it today you would lose (2,444) from holding Apellis Pharmaceuticals or give up 44.27% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 25.71% |
| Values | Daily Returns |
Kinnate Biopharma vs. Apellis Pharmaceuticals
Performance |
| Timeline |
| Kinnate Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Apellis Pharmaceuticals |
Kinnate Biopharma and Apellis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kinnate Biopharma and Apellis Pharmaceuticals
The main advantage of trading using opposite Kinnate Biopharma and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kinnate Biopharma position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.| Kinnate Biopharma vs. ACELYRIN, INC Common | Kinnate Biopharma vs. Windtree Therapeutics | Kinnate Biopharma vs. Palisade Bio | Kinnate Biopharma vs. Century Therapeutics |
| Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. HCW Biologics | Apellis Pharmaceuticals vs. Scpharmaceuticals | Apellis Pharmaceuticals vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |